flypharm limited
flypharm limited Company Information
Company Number
08080553
Next Accounts
Dec 2025
Industry
Other human health activities
Directors
Shareholders
noor afshan ahmed
Group Structure
View All
Contact
Registered Address
bush and company 699 high road, 699 high road, leyton, london, E10 6RA
Website
flypharm.comflypharm limited Estimated Valuation
Pomanda estimates the enterprise value of FLYPHARM LIMITED at £6.3m based on a Turnover of £11.2m and 0.56x industry multiple (adjusted for size and gross margin).
flypharm limited Estimated Valuation
Pomanda estimates the enterprise value of FLYPHARM LIMITED at £3.7m based on an EBITDA of £866.4k and a 4.28x industry multiple (adjusted for size and gross margin).
flypharm limited Estimated Valuation
Pomanda estimates the enterprise value of FLYPHARM LIMITED at £3m based on Net Assets of £1.2m and 2.49x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Flypharm Limited Overview
Flypharm Limited is a live company located in leyton, E10 6RA with a Companies House number of 08080553. It operates in the other human health activities sector, SIC Code 86900. Founded in May 2012, it's largest shareholder is noor afshan ahmed with a 100% stake. Flypharm Limited is a established, mid sized company, Pomanda has estimated its turnover at £11.2m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Flypharm Limited Health Check
Pomanda's financial health check has awarded Flypharm Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 3 areas for improvement. Company Health Check FAQs
6 Strong
1 Regular
3 Weak
Size
annual sales of £11.2m, make it larger than the average company (£730.5k)
- Flypharm Limited
£730.5k - Industry AVG
Growth
3 year (CAGR) sales growth of 113%, show it is growing at a faster rate (7.2%)
- Flypharm Limited
7.2% - Industry AVG
Production
with a gross margin of 22.2%, this company has a higher cost of product (38.4%)
- Flypharm Limited
38.4% - Industry AVG
Profitability
an operating margin of 7.8% make it more profitable than the average company (5.2%)
- Flypharm Limited
5.2% - Industry AVG
Employees
with 145 employees, this is above the industry average (19)
- Flypharm Limited
19 - Industry AVG
Pay Structure
on an average salary of £26.5k, the company has an equivalent pay structure (£26.5k)
- Flypharm Limited
£26.5k - Industry AVG
Efficiency
resulting in sales per employee of £77k, this is more efficient (£45.5k)
- Flypharm Limited
£45.5k - Industry AVG
Debtor Days
it gets paid by customers after 64 days, this is later than average (20 days)
- Flypharm Limited
20 days - Industry AVG
Creditor Days
its suppliers are paid after 23 days, this is slower than average (18 days)
- Flypharm Limited
18 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Flypharm Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Flypharm Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 41.1%, this is a higher level of debt than the average (21.9%)
41.1% - Flypharm Limited
21.9% - Industry AVG
FLYPHARM LIMITED financials
Flypharm Limited's latest turnover from March 2024 is estimated at £11.2 million and the company has net assets of £1.2 million. According to their latest financial statements, we estimate that Flypharm Limited has 145 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 737,058 | 608,701 | ||||||||||
| Other Income Or Grants | 0 | 0 | ||||||||||
| Cost Of Sales | 483,578 | 407,830 | ||||||||||
| Gross Profit | 253,480 | 200,871 | ||||||||||
| Admin Expenses | ||||||||||||
| Operating Profit | ||||||||||||
| Interest Payable | 0 | 0 | ||||||||||
| Interest Receivable | 0 | 0 | ||||||||||
| Pre-Tax Profit | 138,390 | 113,214 | ||||||||||
| Tax | -27,690 | -22,642 | ||||||||||
| Profit After Tax | 110,700 | 90,572 | ||||||||||
| Dividends Paid | 110,020 | 90,580 | ||||||||||
| Retained Profit | 680 | -8 | ||||||||||
| Employee Costs | 35,730 | 23,403 | ||||||||||
| Number Of Employees | 10 | 10 | 10 | 10 | 8 | |||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 47,496 | 49,632 | 49,632 | 51,063 | 52,808 | 54,937 | 46,889 | 46,926 | 47,438 | 47,834 | 47,364 | 47,260 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 187,267 | 540,866 | 579,935 | 336,671 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 47,496 | 49,632 | 236,899 | 591,929 | 632,743 | 391,608 | 46,889 | 46,926 | 47,438 | 47,834 | 47,364 | 47,260 |
| Stock & work in progress | 0 | 0 | 82,690 | 82,690 | 82,690 | 82,690 | 82,690 | 45,699 | 45,699 | 68,000 | 56,000 | 3,000 |
| Trade Debtors | 1,968,221 | 1,488,288 | 0 | 0 | 0 | 0 | 98,025 | 47,830 | 11,706 | 109,503 | 35,619 | 31,136 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 89,928 | 182,737 | 0 | 0 | 0 |
| Cash | 0 | 0 | 622,431 | 664,786 | 382,237 | 307,231 | 439,805 | 400,524 | 224,076 | 117,828 | 18,155 | 19,219 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 1,968,221 | 1,488,288 | 705,121 | 747,476 | 464,927 | 389,921 | 620,520 | 583,981 | 464,218 | 295,331 | 109,774 | 53,355 |
| total assets | 2,015,717 | 1,537,920 | 942,020 | 1,339,405 | 1,097,670 | 781,529 | 667,409 | 630,907 | 511,656 | 343,165 | 157,138 | 100,615 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 559,842 | 714,992 | 507,014 | 740,791 | 136,675 | 140,500 | 667,306 | 500 | 11,705 | 343,057 | 173,989 | 108,699 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 508,965 | 474,175 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 652,082 | 608,756 | 0 | 120,662 | 25,675 | 0 | 0 | 0 |
| total current liabilities | 559,842 | 714,992 | 507,014 | 740,791 | 788,757 | 749,256 | 667,306 | 630,127 | 511,555 | 343,057 | 173,989 | 108,699 |
| loans | 200,000 | 200,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 68,171 | 68,171 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 450 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 268,171 | 268,171 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 450 |
| total liabilities | 828,013 | 983,163 | 507,014 | 740,791 | 788,757 | 749,256 | 667,306 | 630,127 | 511,555 | 343,057 | 173,989 | 109,149 |
| net assets | 1,187,704 | 554,757 | 435,006 | 598,614 | 308,913 | 32,273 | 103 | 780 | 101 | 108 | -16,851 | -8,534 |
| total shareholders funds | 1,187,704 | 554,757 | 435,006 | 598,614 | 308,913 | 32,273 | 103 | 780 | 101 | 108 | -16,851 | -8,534 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Operating Profit | ||||||||||||
| Depreciation | 0 | 1,431 | 1,745 | 2,129 | 2,595 | 945 | 1,180 | 1,410 | 1,290 | 1,090 | ||
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Tax | -27,690 | -22,642 | ||||||||||
| Stock | 0 | -82,690 | 0 | 0 | 0 | 0 | 36,991 | 0 | -22,301 | 12,000 | 53,000 | 3,000 |
| Debtors | 479,933 | 1,301,021 | -353,599 | -39,069 | 243,264 | 238,646 | -39,733 | -56,685 | 84,940 | 73,884 | 4,483 | 31,136 |
| Creditors | -155,150 | 207,978 | -233,777 | 604,116 | -3,825 | -526,806 | 666,806 | -11,205 | -331,352 | 169,068 | 65,290 | 108,699 |
| Accruals and Deferred Income | 0 | 68,171 | 0 | -652,082 | 43,326 | 608,756 | -120,662 | 94,987 | 25,675 | 0 | -450 | 450 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||||||
| Investing Activities | ||||||||||||
| capital expenditure | ||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||||
| Financing Activities | ||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | -508,965 | 34,790 | 474,175 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 200,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||
| interest | 0 | 0 | ||||||||||
| cash flow from financing | 34,789 | 474,176 | ||||||||||
| cash and cash equivalents | ||||||||||||
| cash | 0 | -622,431 | -42,355 | 282,549 | 75,006 | -132,574 | 39,281 | 176,448 | 106,248 | 99,673 | -1,064 | 19,219 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | -622,431 | -42,355 | 282,549 | 75,006 | -132,574 | 39,281 | 176,448 | 106,248 | 99,673 | -1,064 | 19,219 |
flypharm limited Credit Report and Business Information
Flypharm Limited Competitor Analysis
Perform a competitor analysis for flypharm limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in E10 area or any other competitors across 12 key performance metrics.
flypharm limited Ownership
FLYPHARM LIMITED group structure
Flypharm Limited has no subsidiary companies.
Ultimate parent company
FLYPHARM LIMITED
08080553
flypharm limited directors
Flypharm Limited currently has 1 director, Ms Noor Ahmed serving since Feb 2013.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Ms Noor Ahmed | United Kingdom | 48 years | Feb 2013 | - | Director |
P&L
March 2024turnover
11.2m
+160%
operating profit
866.4k
0%
gross margin
22.3%
+3.81%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
1.2m
+1.14%
total assets
2m
+0.31%
cash
0
0%
net assets
Total assets minus all liabilities
flypharm limited company details
company number
08080553
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
May 2012
age
13
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2024
previous names
N/A
accountant
BUSH AND COMPANY ACCOUNTANTS
auditor
-
address
bush and company 699 high road, 699 high road, leyton, london, E10 6RA
Bank
-
Legal Advisor
-
flypharm limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to flypharm limited. Currently there are 1 open charges and 0 have been satisfied in the past.
flypharm limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for FLYPHARM LIMITED. This can take several minutes, an email will notify you when this has completed.
flypharm limited Companies House Filings - See Documents
| date | description | view/download |
|---|
